Practice management requires a human in the loop for the use of artificial intelligence, as well as a "human on the loop" that assures the quality of AI agents handling automated processes, says Michael Clark, Onpoint Healthcare Partners president.

Teresa Cope, CEO of Manx Care, outlines the Isle of Man government's 2026 Innovation Challenge, an initiative designed to attract technology solutions that can support the Island's vision for digitally enabled, sustainable healthcare.

Mati Gill, AION Labs CEO, provides an update on the company’s nine AI-enabled drug discovery portfolio companies, how the organizations are making an impact in life sciences and what’s next for AION, including exploring quantum technologies.

The chief information officer of the 25-bed New Mexico nonprofit discusses plan for some new clinical automation tools. He also describes how he's using AI to help with network defense, and how that's enabling gains in other areas.

The U.S. Food and Drug Administration's validation requirements process for drug development is a good model for healthcare artificial intelligence governance, explains Michael Abrams, managing partner at Numerof & Associates.

H.E. Mubaraka Ibrahim, CIO and chief AI officer of Emirates Health Services, says the country is building an AI governance model that pairs clinical innovation with policy, training and prevention-focused population health.

The Philadelphia health system has committed to returning 10 million hours back to patient care over the next three years using AI, says Dr. Baligh Yehia, president of Jefferson Health.

Eitan Okun, head of the Paul Feder Laboratory for Alzheimer's Disease Research at Bar-Ilan University, discusses the lab's study on the mechanistic link between pregnancy with a Down syndrome fetus and an elevated risk of maternal cognitive decline.